eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
IMPACT FACTOR
2023
1.5
MNiSW
20*
Indexed in:
ESCI

Web of Science
Clarivate Analytics
JCI
0.31

Journal Citation Indicator
CiteScore 2023
2.8
 
NEW Guidelines for Authors!

The current MNiSW score is temporary and results from the decision of the Minister of Science and Higher Education to withdraw scores from all journals that received an increase in score in 2023. The decision is the result of the need to develop a new scoring system. However, all articles published in 2023 are awarded 200 MNiSW points, and the actual score for 2024 will be determined at the end of the year.

Obecna punktacja MEiN ma charakter tymczasowy i wynika z decyzji Ministra Nauki i Szkolnictwa Wyższego o wycofaniu punktacji wszystkim czasopismom, które w 2023 r. uzyskały podwyższenie punktacji. Decyzja ta wynika z konieczności opracowania nowego systemu punktacji. Natomiast wszystkie artykuły opublikowane w roku 2023 otrzymują 200 punktów MNiSW, a ostateczna punktacja za rok 2024 zostanie ustalona na koniec roku.


Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.

Indexed in PubMed and Web of Science Core Collection
1/2021
vol. 7
 
 

 
Review paper

Non-alcoholic fatty liver disease and lipotoxicity

Natalia Wasilewska, Dariusz Marek Lebensztejn
Clin Exp HEPATOL 2021; 7, 1: 1-6
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104441
Original paper

Should patients with unresectable gallbladder cancer with hilar involvement undergo unilateral or bilateral percutaneous biliary drainage in the setting of cholangitis?

Pankaj Gupta, Varun Bansal, Naveen Kalra, Jayanta Samanta, Harshal Mandavdhare, Vishal Sharma, Usha Dutta, Rakesh Kochhar, Manavjit Singh Sandhu
Clin Exp HEPATOL 2021; 7, 1: 7-12
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104674
Original paper

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy

Michał Kukla, Rafał Kierach, Magdalena Skonieczna, Dorota Hudy, Krzysztof Dąbrowski, Tomasz Menżyk, Aleksandra Derra, Dariusz Boroń, Beniamin Oskar Grabarek
Clin Exp HEPATOL 2021; 7, 1: 13-24
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104419
Original paper

The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis

Anas Renno, Yousef Abdel-Aziz, Yaseen Alastal, Sadik Khuder, Syed Hasan, Ragheb Assaly, Ali Nawras
Clin Exp HEPATOL 2021; 7, 1: 25-29
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104488
Original paper

Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters

Narges Abdoli, Issa Sadeghian, Negar Azarpira, Mohammad Mehdi Ommati, Reza Heidari
Clin Exp HEPATOL 2021; 7, 1: 30-40
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104675
Original paper

The usefulness of immunohistochemical staining of bile tracts in biliary atresia

Joanna Cielecka-Kuszyk, Maria Janowska, Małgorzata Markiewicz, Piotr Czubkowski, Anna Ostoja-Chyżyńska, Joanna Beata Bierła, Bożena Cukrowska, Joanna Pawłowska
Clin Exp HEPATOL 2021; 7, 1: 41-46
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104676
Original paper

Predictors of azathioprine toxicity in children with autoimmune hepatitis

Behairy El-Sayed Behairy, Hala Hany El-Said, Hatem Abd-Alsattar Konswa, Ahmed El-Sayed Nour El-Deen, Nermin Mohamed Adawy, Ahmad Mohamed Sira
Clin Exp HEPATOL 2021; 7, 1: 47-54
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104634
Original paper

Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease

Caridad Ruenes Domech, Julio Cesar Fernandez Travieso, Zaily Dorta Guridi, Marlen Ivón Castellanos Fernández, Sacha Lazo del Vallín, Anaisa Rojas Carralero, Elena Ferrer Batallie, Aimeé Marcia Alvarez Alvarez, Lilia Fernández Dorta, José Illnait Ferrer, Sarahi Mendoza Castaño, Maytee Robaina García, Gladys Jiménez Rivero, Yeni Veliz Alvarez
Clin Exp HEPATOL 2021; 7, 1: 55-65
Online publish date: 2021-03-12
 
DOI : https://doi.org/10.5114/ceh.2021.104387
Original paper

Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study

Ahmed Kamal, Amr Aly Abd Elmoety, Yousri Abdelmeguid Rostom, Mohamed Said Shater, Sameh Aldesoky Lashen
Clin Exp HEPATOL 2021; 7, 1: 66-73
Online publish date: 2021-03-11
 
DOI : https://doi.org/10.5114/ceh.2021.104397
Original paper

Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development

Eman Saad Nassar, Yomna Abdelrazek Elkalbashawy, Ahmed Kamal, Nermine Hossam Eldin Zakaria
Clin Exp HEPATOL 2021; 7, 1: 74-78
Online publish date: 2021-03-15
 
DOI : https://doi.org/10.5114/ceh.2021.104385
Original paper

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland

Tadeusz Wojciech Łapiński, Aleksandr Tarasik, Marcin Januszkiewicz, Robert Flisiak
Clin Exp HEPATOL 2021; 7, 1: 79-84
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104631
Original paper

Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients

Aymen Farid Elshayeb, Mohamed Gamal Abdrabu, Sara Lotfy Asar, Mohamed Adel Abdelaziz, Hossam Abuelkheir
Clin Exp HEPATOL 2021; 7, 1: 85-92
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104472
Original paper

Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C

Dorota Orzechowska, Katarzyna Klimowicz, Anna Stępień, Tomasz Mikuła, Mariusz Sapuła, Alicja Wiercińska-Drapało
Clin Exp HEPATOL 2021; 7, 1: 93-100
Online publish date: 2021-03-15
 
DOI : https://doi.org/10.5114/ceh.2021.104466
Original paper

Characterization of CD326-positive human hepatic stem cells

Eva Schmelzer, Giada Pietrosi, Bruno Gridelli, Jörg Gerlach
Clin Exp HEPATOL 2021; 7, 1: 101-110
Online publish date: 2021-03-15
 
DOI : https://doi.org/10.5114/ceh.2021.104459
Original paper

FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study

Roberto Catanzaro, Alice Aleo, Morena Sciuto, Luca Zanoli, Baskar Balakrishnan, Francesco Marotta
Clin Exp HEPATOL 2021; 7, 1: 111-116
Online publish date: 2021-03-25
 
DOI : https://doi.org/10.5114/ceh.2021.104543
Original paper

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy

Agnieszka Stawicka, Magdalena Świderska, Justyna Zbrzeźniak, Natalia Sołowianowicz, Aleksandra Woszczenko, Robert Flisiak, Jerzy Jaroszewicz
Clin Exp HEPATOL 2021; 7, 1: 117-124
Online publish date: 2021-02-02
 
DOI : https://doi.org/10.5114/ceh.2021.103242
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.